Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples